1019|40|Public
5|$|An {{example of}} a {{medicinal}} enzyme inhibitor is sildenafil (Viagra), a common treatment for male erectile dysfunction. This compound is a potent inhibitor of cGMP specific phosphodiesterase type 5, the enzyme that degrades the signalling molecule cyclic <b>guanosine</b> <b>monophosphate.</b> This signalling molecule triggers smooth muscle relaxation and allows blood flow into the corpus cavernosum, which causes an erection. Since the drug decreases {{the activity of the}} enzyme that halts the signal, it makes this signal last {{for a longer period of}} time.|$|E
25|$|The NO {{produced}} by {{this process is}} a potent activator of guanylyl cyclase (GC) by heme-dependent mechanisms; this activation results in formation of cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP) from guanosine triphosphate (GTP). Among other roles, cGMP serves as a substrate for a cGMP-dependent protein kinase that activates myosin light chain phosphatase. Thus, production of NO from exogenous sources such as GTN increases the level of cGMP within the cell, and stimultates dephosphorylation of myosin.|$|E
25|$|The {{choice of}} fluids for {{resuscitation}} remains {{an area of}} research, the Surviving Sepsis Campaign an international consortium of experts, did not find adequate {{evidence to support the}} superiority crystalloid fluids versus colloid fluids. Drugs such as, pyridoxalated hemoglobin polyoxyethylene, which scavenge nitric oxide from the blood have been investigated. As well as methylene blue which may inhibit the nitric oxide-cyclic <b>guanosine</b> <b>monophosphate</b> (NO-cGMP) pathway which has been suggested to {{play a significant role in}} distributive shock.|$|E
5000|$|... #Article: Cyclic <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> ...|$|R
25|$|Decreases sodium {{reabsorption}} in {{the distal}} convoluted tubule (interaction with NCC) and cortical collecting duct of the nephron via <b>guanosine</b> 3',5'-cyclic <b>monophosphate</b> (cGMP) dependent phosphorylation of ENaC.|$|R
40|$|AbstractLow-density lipoproteins {{activate}} isolated human platelets. The {{mechanism of}} this activation is unknown, but may involve increased phosphoinositide turnover. We {{have examined the}} effect of low-density lipoproteins on intracellular calcium concentrations in platelets loaded with the photoprotein aequorin. The lipoproteins induced concentration-dependent increases in intracellular calcium, associated with shape change and aggregation. These responses could be partially inhibited by the removal of extracellular calcium and by pre-incubation with acetylsalicylic acid. They were also antagonised by agents which increase cellular concentrations of cyclic adenosine and <b>guanosine</b> <b>monophosphates.</b> It {{is not clear whether}} the platelet-lipoprotein interaction involves a ‘classical’ lipoprotein receptor...|$|R
25|$|Sildenafil protects cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP) from {{degradation}} by cGMP-specific phosphodiesterase type 5 (PDE5) in {{the corpus}} cavernosum. Nitric oxide (NO) in the corpus cavernosum of the penis binds to guanylate cyclase receptors, {{which results in}} increased levels of cGMP, leading to smooth muscle relaxation (vasodilation) of the intimal cushions of the helicine arteries. This smooth muscle relaxation leads to vasodilation and increased inflow of blood into the spongy tissue of the penis, causing an erection. Robert F. Furchgott, Ferid Murad, and Louis Ignarro won the Nobel Prize in Physiology or Medicine in 1998 for their independent study of the metabolic pathway of nitric oxide in smooth muscle vasodilation.|$|E
25|$|The binding of {{melatonin}} to melatonin receptors activates a few signaling pathways. MT1 receptor activation inhibits the adenylyl cyclase and its inhibition {{causes a}} rippling effect of non activation; starting with decreasing formation of {{cyclic adenosine monophosphate}} (cAMP), and then progressing to less protein kinase A (PKA) activity, which in turn hinders the phosphorylation of cAMP responsive element-binding protein (CREB binding protein) into P-CREB. MT1 receptors also activate phospholipase C (PLC), affect ion channels and regulate ion flux inside the cell. The binding of melatonin to MT2 receptors inhibits adenylyl cyclase which decreases the formation of cAMP. As well it hinders guanylyl cyclase and therefore the forming of cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP). Binding to MT2 receptors probably affects PLC which increases protein kinase C (PKC) activity. Activation of the receptor can lead to ion flux inside the cell.|$|E
25|$|While some {{mutations}} in CNGA3 result in truncated and, presumably, non-functional channels this is largely not the case. While few mutations have received in-depth study, see table 1, {{at least one}} mutation does result in functional channels. Curiously, this mutation, T369S, produces profound alterations when expressed without CNGB3. One such alteration is decreased affinity for Cyclic <b>guanosine</b> <b>monophosphate.</b> Others include {{the introduction of a}} sub-conductance, altered single-channel gating kinetics, and increased calcium permeability. When mutant T369S channels coassemble with CNGB3, however, the only remaining aberration is increased calcium permeability. While it is not immediately clear how this increase in Ca2+ leads to ACHM, one hypothesis is that this increased current decreases the signal-to-noise ratio. Other characterized mutations, such as Y181C and the other S1 region mutations, result in decreased current density due to an inability of the channel to traffic to the surface. Such loss of function will undoubtedly negate the cone cell's ability to respond to visual input and produce achromatopsia. At least one other missense mutation outside of the S1 region, T224R, also leads to loss of function.|$|E
50|$|Allopurinol is a purine analog; it is a {{structural}} isomer of hypoxanthine (a naturally occurring purine in the body) {{and is an}} inhibitor of the enzyme xanthine oxidase. Xanthine oxidase {{is responsible for the}} successive oxidation of hypoxanthine and xanthine, resulting in the production of uric acid, the product of human purine metabolism. In addition to blocking uric acid production, inhibition of xanthine oxidase causes an increase in hypoxanthine and xanthine. While xanthine cannot be converted to purine ribotides, hypoxanthine can be salvaged to the purine ribotides adenosine and <b>guanosine</b> <b>monophosphates.</b> Increased levels of these ribotides may cause feedback inhibition of amidophosphoribosyl transferase, the first and rate-limiting enzyme of purine biosynthesis. Allopurinol, therefore, decreases uric acid formation and may also inhibit purine synthesis.|$|R
50|$|Cyclic GMP-AMP synthase (cGAS), which {{belongs to}} the {{nucleotidyltransferase}} family, is able to recognize cytosolic DNA contents and induce STING-dependent interferon response by producing secondary messenger cyclic <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> (cyclic GMP-AMP, or cGAMP). After cyclic GMP-AMP bound STING is activated, it enhances TBK1's activity to phosphorylate IRF3 and STAT6 for downstream type I interferon response.|$|R
40|$|This work {{demonstrates}} {{the development of}} highly sensitive and selective analytical methods, which {{make use of the}} hyphenation of high performance ion chromatography (HPIC) to inductively coupled plasma sector field mass spectrometry (ICP-SFMS). On-line coupling a chromatographic separation method with an elemental detection method provides two advantages: (1) the components of a possibly interfering matrix can be separated allowing accurate and precise ultra trace analysis of the element of interest and (2) elemental species of an element can be separated and quantified. In this work, matrix separation methods for interference free determination of 232 Th, 234 U, 235 U and 238 U in geological matrices were developed and employed. Furthermore HPIC-ICP-SFMS was applied for ultra trace analysis of Pd in environmental and geological matrices. The usefulness of HPIC-ICP-SFMS for speciation studies was demonstrated by investigating the interaction of an anti-cancer drug (cisplatin) with <b>guanosine</b> <b>monophosphates...</b>|$|R
25|$|Ammonia {{toxicity}} {{is often}} seen through two routes of administration, either through consumption or through endogenous ailments such as liver failure. One notable case in which ammonia toxicity is common {{is in response to}} cirrhosis of the liver which results in hepatic encephalopathy, and can result in cerebral edema (Haussinger 2006). This cerebral edema can be the result of nervous cell remodeling. As a consequence of increased concentrations, ammonia activity in-vivo has been shown to induce swelling of astrocytes in the brain through increased production of cGMP (Cyclic <b>Guanosine</b> <b>Monophosphate)</b> within the cells which leads to Protein Kinase G-mediated(PKG) cytoskeletal modifications. The resultant effect of this toxicity can be reduced brain energy metabolism and function. Importantly, the toxic effects of ammonia on astrocyte remodling can be reduced through administration of L-carnitine. This astrocyte remodeling appears to be mediated through ammonia-induced mitochondrial permeability transition. This mitochondrial transition {{is a direct result of}} glutamine activity a compound which forms from ammonia in-vivo. Administration of antioxidants or glutaminase inhibitor can reduce this mitochondrial transition, and potentially also astrocyte remodeling.|$|E
25|$|H2S therapy uses a H2S donor, such as diallyl trisulfide (DATS), to {{increase}} the supply of H2S to an AMI patient. H2S donors reduce myocardial injury and reperfusion complications. Increased H2S levels within the body will react with oxygen to produce sulfane sulfur, a storage intermediate for H2S. H2S pools in the body attracts oxygen to react with excess H2S and eNOS {{to increase}} NO production. With increased use of oxygen to produce more NO, less oxygen is available to react with eNOS to produce superoxides during an AMI, ultimately lowering the accumulation of reactive oxygen species (ROS). Furthermore, decreased accumulation of ROS lowers oxidative stress in vascular smooth muscle cells, decreasing oxidative degeneration of BH4. Increased BH4 cofactor contributes to increased production of NO within the body. Higher concentrations of H2S directly increase eNOS activity through Akt activation to increase phosphorylation of the eNOSS1177 activation site, and decrease phosphorylation of the eNOST495 inhibition site. This phosphorylation process upregulates eNOS activity, catalyzing more conversion of L-arginine to NO. Increased NO production enables soluble guanylyl cyclase (sGC) activity, leading to an increased conversion of guanosine triphosphate (GTP) to 3’,5’-cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP). In H2S therapy immediately following an AMI, increased cGMP triggers an increase in protein kinase G (PKG) activity. PKG reduces intracellular Ca2+ in vascular smooth muscle to increase smooth muscle relaxation and promote blood flow. PKG also limits smooth muscle cell proliferation, reducing intima thickening following AMI injury, ultimately decreasing myocardial infarct size.|$|E
2500|$|Comparative {{homology}} modelling of {{the enzyme}} Hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8) [...] in L. donovani suggest that {{among all of}} the computationally screened compounds, pentamidine, 1,3-dinitroadamantane, acyclovir and analogs of acyclovir had higher binding affinities than the real substrate (<b>guanosine</b> <b>monophosphate).</b>|$|E
40|$|<b>Guanosine</b> <b>monophosphates</b> (GMPs) were {{intercalated}} {{into the}} interlayer space of layered double hydroxides (LDHs) and the molecular arrangement of GMP was controlled in LDHs. The intercalation {{conditions such as}} GMP/LDH molar ratio and reaction temperature were systematically adjusted. When the GMP/LDH molar ratio was 1 : 2, which corresponds to the charge balance between positive LDH sheets and GMP anions, GMP molecules were well-intercalated to LDH. At high temperature (100 and 80 °C), a single GMP molecule existed separately in the LDH interlayer. On the other hand, at lower temperature (20, 40 and 60 °C), GMPs tended to form ribbon-type supramolecular assemblies. Differential scanning calorimetry showed that the ribbon-type GMP assembly had an intermolecular interaction energy of ≈ 101 kJ/mol, which corresponds to a double hydrogen bond between guanosine molecules. Once stabilized, the interlayer GMP orientations, single molecular and ribbon phase, were successfully converted to the other phase by adjusting the external environment by stoichiometry or temperature control...|$|R
5000|$|Cyclic <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> (cyclic GMP-AMP, cGAMP) is {{the first}} cyclic di-nucleotide found in metazoa. [...] In {{mammalian}} cells, cGAMP is synthesized by cyclic GMP-AMP synthase (cGAS) from ATP and GTP upon cytosolic DNA stimulation. cGAMP produced by cGAS contains mixed phosphodiester linkages, with one between 2'-OH of GMP and 5'-phosphate of AMP and the other between 3'-OH of AMP and 5'-phosphate of GMP.|$|R
40|$|AbstractThe goal of {{this work}} is to {{determine}} the proton affinities of (deoxy) nucleoside 5 ′- and 3 ′-monophosphates (mononucleotides) using the kinetic method with fast atom bombardment mass spectrometry. The proton affinities of the (deoxy) nucleoside 5 ′- and 3 ′-monophosphates yielded the following trend: (deoxy) adenosine <b>monophosphates</b> > (deoxy) <b>guanosine</b> <b>monophosphates</b> > (deoxy) cytidine monophosphates ≫ deoxythymidine/uridine monophosphates. In all cases the proton affinity decreases or remains the same with the addition of the phosphate group from those values reported for nucleosides. The proton affinity is dependent on the location of the phosphate backbone (5 ′- vs. 3 ′-phosphates) : the 3 ′-monophosphates have lower proton affinities than the 5 ′-monophosphates except for the thymidine/uridine monophosphates where the trend is reversed. Molecular modeling was utilized to determine if multiple protonation sites and intramolecular hydrogen bond formation would influence the proton affinity measurements. Semiempirical calculations of the proton affinities at various locations on each mononucleotide were performed and compared to the experimental results. The possible influence of intramolecular hydrogen bonding between the nucleobases and the phosphate group on the measured and calculated proton affinities is discussed...|$|R
2500|$|The {{two most}} well-studied cyclic {{nucleotides}} are cyclic AMP (cAMP) and cyclic GMP (cGMP), while cyclic CMP (cCMP) and cyclic UMP (cUMP) are less understood. [...] cAMP is 3’5’-cyclic adenosine monophosphate, cGMP is 3’5’-cyclic <b>guanosine</b> <b>monophosphate,</b> cCMP is cytidine 3',5'-monophosphate, and cUMP is uridine 2',3'-cyclic phosphate.|$|E
2500|$|A cyclic {{nucleotide}} (cNMP) is a single-phosphate nucleotide with a cyclic bond arrangement {{between the}} sugar and phosphate groups. [...] Like other nucleotides, cyclic nucleotides are composed of three functional groups: a sugar, a nitrogenous base, and a single phosphate group. [...] As {{can be seen in}} the cyclic adenosine monophosphate (cAMP) and cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP) images, the 'cyclic' portion consists of two bonds between the phosphate group and the 3' and 5' hydroxyl groups of the sugar, very often a ribose.|$|E
2500|$|... eNOS has a {{protective}} {{function in the}} cardiovascular system, which is attributed to NO production. Regulation of the vascular tone {{is one of the}} best known roles of NO in the cardiovascular system. Once produced in endothelial cells, NO diffuses across the vascular smooth muscle cell membranes and activates the enzyme soluble guanylate cyclase (sGC), which catalyzes the conversion of guanosine triphosphate into cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP). cGMP, in turn, activates protein kinase G (PKG), which promotes multiple phosphorylation of cellular targets lowering cellular Ca2+ concentrations and promoting vascular relaxation.|$|E
50|$|Depolarization of rod cells (causing {{release of}} their neurotransmitter) occurs {{because in the}} dark, cells have a {{relatively}} high concentration of cyclic <b>guanosine</b> 3'-5' <b>monophosphate</b> (cGMP), which opens ion channels (largely sodium channels, though calcium can enter through these channels as well). The positive charges of the ions that enter the cell down its electrochemical gradient change the cell's membrane potential, cause depolarization, and lead {{to the release of}} the neurotransmitter glutamate. Glutamate can depolarize some neurons and hyperpolarize others, allowing photoreceptors to interact in an antagonistic manner.|$|R
50|$|Activation of {{rods and}} cones is {{actually}} hyperpolarization; {{when they are}} not being stimulated, they depolarize and release glutamate continuously. In the dark, cells have a relatively high concentration of cyclic <b>guanosine</b> 3'-5' <b>monophosphate</b> (cGMP), which opens ion channels (largely sodium channels, though calcium can enter through these channels as well). The positive charges of the ions that enter the cell down its electrochemical gradient change the cell's membrane potential, cause depolarization, and lead to the release of the neurotransmitter glutamate. Glutamate can depolarize some neurons and hyperpolarize others.|$|R
50|$|In some occasions, DNA and RNA {{may contain}} some minor bases. Methylated {{forms of the}} major bases are most common in DNA. In viral DNA, some bases may be hydroxymethylated or glucosylated. In RNA, minor or {{modified}} bases occur more frequently. Some examples include hypoxanthine, dihydrouracil, methylated forms of uracil, cytosine, and guanine, as well as modified nucleoside pseudouridine. Nucleotides with phosphate groups in positions other than on the 5' carbon have also been observed. Examples include ribonucleoside 2',3'-cyclic monophosphates which are isolatable intermediates, and ribonucleoside 3'-monophosphates which are end products of the hydrolysis of RNA by certain ribonucleases. Other variations include adenosine 3',5'-cyclic <b>monophosphate</b> (cAMP) and <b>guanosine</b> 3',5'-cyclic <b>monophosphate</b> (cGMP).|$|R
2500|$|Evgeny Fesenko, Stanislav Kolesnikov, and Arkady Lyubarsky {{discovered}} in 1985 that cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP) can initiate the photoresponse in rods. Soon after, {{the role of}} cNMP in gated ion channels of chemosensitive cilia of olfactory sensory neurons was reported by Tadashi Nakamura and Geoffrey Gold. In 1992 Lawrence Haynes and King-Wai Yau uncovered cNMP’s role in the light-dependent cyclic-nucleotide-gated channel of cone photoreceptors. By {{the end of the}} decade, the presence of two types of intramembrane receptors was understood: Rs (which stimulates cyclase) and Ri (which inhibits cyclase). [...] Wei-Jen Tang and James Hurley reported in 1998 that adenylyl cyclase, which synthesizes cAMP, is regulated not only by hormones and neurotransmitters, but also by phosphorylation, calcium, forskolin, and guanine nucleotide-binding proteins (G proteins).|$|E
50|$|<b>Guanosine</b> <b>monophosphate</b> synthetase, (EC 6.3.5.2) {{also known}} as GMPS is an enzyme that {{converts}} xanthosine monophosphate to <b>guanosine</b> <b>monophosphate.</b>|$|E
50|$|For example, it {{converts}} {{adenosine monophosphate}} to adenosine, and <b>guanosine</b> <b>monophosphate</b> to guanosine.|$|E
5000|$|Similar to its {{endogenous}} counterpart, Plecanatide activates guanylate cyclase-C on endothelial cells {{within the}} gastrointestinal tract. [...] The activation of guanylate cyclase-C catalyses {{the production of}} the second messenger <b>guanosine</b> 3’,5’-cyclic <b>monophosphate</b> (cGMP) which leads to the protein kinase A (PKA) and protein kinase G II (PKGII)-mediated phosphorylation of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. CFTR is an anion channel and upon activation it will secrete negatively charged ions, particularly chloride (Cl−) and bicarbonate (HCO3−) in to the GI tract lumen. This disruption to the electrochemical gradient is in part rectified by the passive secretion of positively charged sodium ions in to the lumen and water follows by osmosis.|$|R
30|$|The host takes use {{of pattern}} {{recognition}} receptors (PRRs) {{to defend against}} pathogen invasion or cellular damage. Among microorganism-associated molecular patterns detected by host PRRs, nucleic acids derived from bacteria or viruses are tightly supervised, providing a fundamental mechanism of host defense. Pathogenic DNAs {{are supposed to be}} detected by DNA sensors that induce the activation of NFκB or TBK 1 -IRF 3 pathway. DNA sensor cGAS is widely expressed in innate immune cells and is a key sensor of invading DNAs in several cell types. cGAS binds to DNA, followed by a conformational change that allows the synthesis of cyclic <b>guanosine</b> monophosphate–adenosine <b>monophosphate</b> (cGAMP) from adenosine triphosphate and guanosine triphosphate. cGAMP is a strong activator of STING that can activate IRF 3 and subsequent type I interferon production. Here we describe recent progresses in DNA sensors especially cGAS in the innate immune responses against pathogenic DNAs.|$|R
40|$|SummaryActivation of the DNA-dependent cytosolic {{surveillance}} pathway {{in response}} to Mycobacterium tuberculosis infection stimulates ubiquitin-dependent autophagy and inflammatory cytokine production, and {{plays an important role}} in host defense against M.  tuberculosis. However, the identity of the host sensor for M.  tuberculosis DNA is unknown. Here we show that M.  tuberculosis activated cyclic <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> (cGAMP) synthase (cGAS) in macrophages to produce cGAMP, a second messenger that activates the adaptor protein stimulator of interferon genes (STING) to induce type I interferons and other cytokines. cGAS localized with M.  tuberculosis in mouse and human cells and in human tuberculosis lesions. Knockdown or knockout of cGAS in human or mouse macrophages blocked cytokine production and induction of autophagy. Mice deficient in cGAS were more susceptible to lethality caused by infection with M.  tuberculosis. These results demonstrate that cGAS is a vital innate immune sensor of M.  tuberculosis infection...|$|R
50|$|Degradation of cyclic di-GMP to <b>guanosine</b> <b>monophosphate</b> (GMP) is catalyzed by a {{phosphodiesterase}} (PDE).|$|E
50|$|As {{inhibitor}} of <b>guanosine</b> <b>monophosphate</b> synthesis {{in experimental}} models, the glutamine analogue DON can be used.|$|E
5000|$|Guanylate cyclase catalyzes the {{reaction}} of guanosine triphosphate (GTP) to 3',5'-cyclic <b>guanosine</b> <b>monophosphate</b> (cGMP) and pyrophosphate: ...|$|E
40|$|Dendritic cell (DC) {{activation}} and {{antigen presentation}} {{are critical for}} efficient priming of T cell responses. Here, we study how lentiviral vectors (LVs) deliver antigen and activate DCs to generate T cell immunization in vivo. We report that antigenic proteins delivered in vector particles via pseudotransduction were sufficient to stimulate an antigen-specific immune response. The delivery of the viral genome encoding the antigen increased {{the magnitude of this}} response in vivo but was irrelevant in vitro. Activation of DCs by LVs was independent of MyD 88, TRIF, and MAVS, ruling out an involvement of Toll-like receptor or RIG-I–like receptor signaling. Cellular DNA packaged in LV preparations induced DC activation by the host STING (stimulator of interferon genes) and cGAS (cyclic <b>guanosine</b> monophosphate–adenosine <b>monophosphate</b> synthase) pathway. Envelope-mediated viral fusion also activated DCs in a phosphoinositide 3 -kinase–dependent but STING-independent process. Pseudotransduction, transduction, viral fusion, and delivery of cellular DNA collaborate to make the DC-targeted LV preparation an effective immunogen...|$|R
40|$|The {{presence}} of DNA in the cytoplasm of mammalian cells {{is a danger}} signal that triggers host immune responses such as the production of type I interferons. Cytosolic DNA induces interferons through the production of cyclic <b>guanosine</b> monophosphate–adenosine <b>monophosphate</b> (cyclic GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING. Through biochemical fractionation and quantitative mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family. Overexpression of cGAS activated the transcription factor IRF 3 and induced interferon-b in a STING-dependent manner. Knockdown of cGAS inhibited IRF 3 activation and interferon-b induction by DNA transfection or DNA virus infection. cGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis. These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP. DNA was known to stimulate immuneresponses long before it was shown to bea genetic material, but the mechanism by which DNA functions as an immune stim-ulant remains poorly understood (1). Although DNA can stimulate the production of type I in-terferons in dendritic cells through binding t...|$|R
40|$|Modified {{vaccinia virus}} Ankara (MVA) is an {{attenuated}} poxvirus {{that has been}} engineered as a vaccine against infectious agents and cancers. Our goal is to understand how MVA modulates innate immunity in dendritic cells (DCs), which can provide insights to vaccine design. In this study, using murine bone marrow-derived dendritic cells, we assessed type I interferon (IFN) gene induction and protein secretion in response to MVA infection. We report that MVA infection elicits the production of type I IFN in murine conventional dendritic cells (cDCs), but not in plasmacytoid dendritic cells (pDCs). Transcription factors IRF 3 (IFN regulatory factor 3) and IRF 7, and the positive feedback loop mediated by IFNAR 1 (IFN alpha/ beta receptor 1), are required for the induction. MVA induction of type I IFN is fully dependent on STING (stimulator of IFN genes) and the newly discovered cytosolic DNA sensor cGAS (cyclic <b>guanosine</b> monophosphate-adenosine <b>monophosphate</b> synthase). MVA infection of cDCs triggers phosphorylation of TBK 1 (Tank-binding kinase 1) and IRF 3, which is abolished {{in the absence of}} cGAS and STING. Furthermore, intravenous delivery of MVA induces type I IFN in wild-type mice, but not i...|$|R
